EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

Squamous cell carcinoma of the head and neck (SCCHN) is a prevalent disease both in the United States and worldwide with an overall poor prognosis, in part due to limited activity of existing therapy. Primary therapy is largely dictated by the anatomical origin of the cancer and whether distant dise...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Kono, Scott A., Haigentz, Missak, Yom, Sue S., Saba, Nabil
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465896/
https://ncbi.nlm.nih.gov/pubmed/23056941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/901320
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares